Hybrid Service Model

Our hybrid of intelligence and technology platforms provide a distinctive end-to-end service model, designed to reduce time and risk with custom applications. We support our business partners in the quest to discover and develop novel antibodies against a broad range of classes of disease targets in “one-stop”, with:? An unrivaled suite of services. Target design and antigen modeling. A broad range of immunization technologies in a multitude of species and strains. Best-in-class hybridoma, B-cell, and phage display antibody discovery platforms. Antibody characterization, engineering, and manufacturing services?.